Early research (Phase 1)Study completedNCT06291948What this trial is testingA Clinical Study With Adalimumab BiosimilarWho this might be right forPharmacokineticsSafety Issues Laboratorios Richmond S.A.C.I.F. 150
Large-scale testing (Phase 3)Study completedNCT03773978What this trial is testingBaricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis Eli Lilly and Company 220